Results 11 to 20 of about 451 (159)

Bioinspired Lipoproteins of Furoxans–Gemcitabine Preferentially Targets Glioblastoma and Overcomes Radiotherapy Resistance [PDF]

open access: yesAdvanced Science
Radiotherapy (RT) resistance is an enormous challenge in glioblastoma multiforme (GBM) treatment, which is largely associated with DNA repair, poor distribution of reactive radicals in tumors, and limited delivery of radiosensitizers to the tumor sites ...
Maoyuan Sun   +10 more
doaj   +3 more sources

Synthesis of alkynyl furoxans. Rare carbon–carbon bond-forming reaction on a furoxan ring [PDF]

open access: yesOrganic & Biomolecular Chemistry, 2017
A novel C–C bond-forming reaction, alkynylation, on a furoxan ring is described.
Ryosuke Matsubara   +3 more
core   +4 more sources

4-Amino-3-(1-{[amino(3-methyl-2-oxido-1,2,5-oxadiazol-4-yl)methylene]hydrazinylidene}ethyl)-1,2,5-oxadiazole 2-Oxide

open access: yesMolbank, 2022
Functionally substituted 1,2,5-oxadiazole 2-oxides (furoxans) are important pharmaceutical scaffolds used for the preparation of various pharmacologically active substances.
Margarita A. Epishina   +2 more
doaj   +2 more sources

Exploring the Anticancer Potential of NO-Donor Oxadiazole Assemblies Against Malignant Pleural Mesothelioma [PDF]

open access: yesPharmaceutics
Background: Nitric oxide (NO) has been linked to the pathogenesis of asbestos-related pleural diseases, including an extremely aggressive cancer called malignant pleural mesothelioma (MPM). Given that MPM cells are characterized by a higher expression of
Irina A. Stebletsova   +5 more
doaj   +2 more sources

Synthesis and Synthetic Application of Chloro- and Bromofuroxans [PDF]

open access: yes, 2020
Furoxans are potentially useful heteroaromatic units in pharmaceuticals and agrichemicals. However, the applications for furoxan-based compounds have been hampered due to the underdevelopment of their synthetic methods.
Hayu Hasebe   +11 more
core   +12 more sources

Synthesis and Characterisation of Diaryl Furoxans

open access: yesDefence Science Journal, 2006
The paper discusses the synthesis, characterisation, and performance evaluation of diarylfuroxans namely, bis-phenyl-3,4-furoxan (5) and bis-(4’-nitrophenyl)-3,4-furoxan (6). Themolecules have been synthesised on the lines of reported method by cyclodimerisation of thenitrile oxides generated from benzaldoxime and p-nitro benzaldoxime, respectively ...
V. N. Krishnamurthy   +4 more
openaire   +3 more sources

Furoxans (Oxadiazole‑4N‑oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory

open access: yes, 2018
Nitric oxide (NO) mimetics and other agents capable of enhancing NO/cGMP signaling have demonstrated efficacy as potential therapies for Alzheimer’s disease.
Qasim Alhadidi (4026488)   +15 more
core   +5 more sources

Quantum chemical research of the molecular structure of 3,4-dicyanofuroxan

open access: yesТонкие химические технологии, 2023
Objectives. The study set out to determine the equilibrium parameters of the 3,4-dicyanofuroxan molecule by means of molecule geometry optimization by quantum chemistry methods, verify the adequacy of the methods used, and compare the obtained results ...
I. N. Kolesnikova   +3 more
doaj   +1 more source

Potassium (3-Methyl-2-oxido-1,2,5-oxadiazol-4-yl)dinitromethanide

open access: yesMolbank, 2021
Furoxan derivatives enriched with explosophoric functionalities are promising compounds in the preparation of novel energetic materials. Herein, a previously unknown potassium (3-methyl-2-oxido-1,2,5-oxadiazol-4-yl)dinitromethanide (also referred to as ...
Egor S. Zhilin   +2 more
doaj   +1 more source

Peptide-Based Biomaterials as a Promising Tool for Cancer Radiotherapy. [PDF]

open access: yesAdv Sci (Weinh)
This review provides a systematic overview of peptide‐based biomaterials in tumor radiotherapy, covering their roles as both radiosensitizers and radiopharmaceuticals. Peptide‐based radiosensitizers are generally divided into three categories: peptides as direct radiosensitizers, peptides as carriers of radiosensitizers, and targeted‐peptide‐modified ...
Wang Q, Chu X, Liu J.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy